Gurugram, Oct. 13 -- Fortis Memorial Research Institute (FMRI), Gurugram recently held the HemeNext 2.0, a two-day international scientific conclave bringing together Indian and global experts to translate advances in blood science into more precise, accessible, and affordable care.

India's cancer burden was estimated at 14.6 lakh new cases in 2022 by the Indian Council of Medical Research-National Cancer Registry Programme (ICMR-NCRP). Lymphoid leukaemia was the leading childhood cancer, accounting for approximately 29% of cancers among boys and 24% among girls aged 0-14 years, underscoring the need for timely diagnosis and sustained access to specialised treatment.

Held on October 10, 11 at The Westin, Sector 29, Gurugram, and led by ...